Key facts
- QUMEA’s last known valuation is $29.4M (Jan 2024).
- It has raised $13.0M; the latest was PE Growth/Expansion in Oct 2025.
- Notable investors include Zürcher Kantonalbank, NEXT Mannheim, GRO Capital, PB Invest, Schaublin Medica — 6 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for QUMEA
- ·The full record, as it builds
Funding rounds
No funding rounds for QUMEA are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About QUMEA
Developer of a contactless mobility monitoring platform designed for patient safety in healthcare institutions. The company's platform utilizes artificial intelligence to monitor patient movement without physical contact, offering real-time alerts, data analytics, and integration with hospital systems, enabling healthcare providers to enhance patient safety, reduce fall risks, and improve workflow efficiency in clinical environments
- Sector
- Healthcare
- HQ
- Solothurn, Switzerland
- Founded
- 2019
- Employees
- 40
- Website
- qumea.com/
- Ownership
- Privately Held (backing)
QUMEA doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in QUMEA shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on QUMEA in its N-PORT filings yet. We sweep new filings monthly.